|
|
|
1-10 employees
View all
|
|
Biotechnology
|
|
Level 5, Catherine Helen Spence Building, UniSA City West Campus, Adelaide , South Australia 5000, AU
|
|
Carina Biotech
An Australian pre-clinical immunotherapy company established to research and develop chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers. Carina are working towards producing broad-spectrum CAR-T therapies that can be used to treat multiple solid cancers yet are patient-specific and result in little, if any, off-cancer damage. Using its proprietary platforms, Carina is also developing technologies to improve access to, and infiltration of, solid cancers, and to enhance CAR-T cell manufacturing.
We are working to…
1. Expand the clinical indications for T cell therapies
2. Improve the commercial viability of T cell therapies by developing supporting technologies that make T cell therapies more effective or economically viable
Headquartered in Adelaide, South Australia, Carina has strong T cell R&D capability across a network of research providers and collaborators including leading scientists at the UniSA, the Women's & Children's Hospital in Adelaide, the University of Adelaide, the Royal Prince Alfred Hospital in NSW and the Seattle Children's Hospital in the United States.
|
Carina Biotech Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Carina Biotech email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Carina Biotech customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.